Argos Therapeutics, Inc. Named As A Red Herring Top 100 North America Winner
Published: May 27, 2014
DURHAM, N.C., May 27, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that the company has been selected as a Red Herring Top 100 North America winner. Each year Red Herring, a technology and business magazine and online news source, honors 100 outstanding entrepreneurs and promising companies as award winners from among approximately 3,000 companies financed annually in the US and Canada.
Help employers find you! Check out all the jobs and post your resume.